Direkt zum Inhalt
Merck
  • LDOC1 gene expression in two patients with head and neck squamous cell carcinomas and Parkinson's disease.

LDOC1 gene expression in two patients with head and neck squamous cell carcinomas and Parkinson's disease.

Tumori (2012-07-25)
Michele Salemi, Domenica Giuffrida, Maria C Giuffrida, Pier Franco Soma, Alessandro Rolfo, Laura Cimino, Rosita A Condorelli, Roberto Castiglione, Sandro La Vignera, Aldo E Calogero
ZUSAMMENFASSUNG

Head and neck squamous cell carcinoma (HNSCC) is one of the most common cancers in the world. Risk factors for this cancer include tobacco and alcohol use, ultraviolet light exposure, and viral infection. Parkinson's disease is one of the most common neurodegenerative disorders, with a prevalence of 3% in persons over the age of 65 years. Apoptosis is a programmed cell death machinery pivotal for normal development, the establishment of highly organized neuronal circuitry, and the elimination of cancer cells. It has been suggested that increased expression of proapoptotic genes is associated with head tumors. One of these genes is the leucine zipper, down-regulated in cancer 1 (LDOC1) gene. We report two interesting cases of a 79-year-old man and a 98-year-old woman, both with Parkinson's disease and well-differentiated multiple HNSCC, in whom we evaluated the possible differential expression of LDOC1. We found that LDOC1 gene expression was increased in both patients compared with three male and three female controls. Conclusions. These findings suggest that apoptosis may play a pathogenetic role in HNSCC.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Glyceraldehyd-3-Phosphat-Dehydrogenase aus Kaninchenmuskel, lyophilized powder, ≥75 units/mg protein
Supelco
GAPDH, standard for protein electrophoresis
Sigma-Aldrich
Glyceraldehyde-3-phosphate Dehydrogenase from human erythrocytes, lyophilized powder, 50-150 units/mg protein